Stock Market

Vaxart (NASDAQ:VXRT) is a clinical-stage biotech company focused on commercializing orally-delivered vaccines. VXRT stock has been volatile in 2021, thanks to hopes and setbacks related to its potential Covid-19 vaccine product. Source: Ascannio / Shutterstock.com However, Vaxart is more than just a quick Covid-19 play. The company’s platform, more broadly, is focused around trying to make
0 Comments
In 2020, every macro trend could not go more right for Peleton (NASDAQ:PTON) and PTON stock. Last year was, at-best, mediocre period for the  exercise-equipment maker in terms of the macro situation. And late last year, the situation turned quite negative for the company and its shares. Source: JHVEPhoto / Shutterstock.com Now all signs are
0 Comments
Online trading platform Robinhood (NASDAQ:HOOD) has its fair share of detractors. Critics claim that the company takes advantage of retail investors, has turned buying and selling stocks into an addictive game and is not upfront about the fees it charges for making trades on its platform, a worrying trend for investors looking at Robinhood stocks.
0 Comments
I am of two minds concerning Clover Health (NASDAQ:CLOV) and CLOV Stock. Source: Wirestock Creators / Shutterstock.com I’m intrigued by Clover’s chief technology officer Andrew Toy’s plans to cut the cost of serving older patients through the Clover Assistant. The Assistant is a clinical support system that makes extensive use of telehealth and mail-in pharmacies,
0 Comments
You don’t have to dig too deep to encounter the mantra that everyone loves repeating: electric vehicles are the future. Through simple deduction, if EVs are the future, then the infrastructure to support the electrification of transportation is also the future. And voila! You have EVgo (NASDAQ:EVGO), a charging station provider. You couldn’t ask for
0 Comments
Major social media platforms have been dominant monopolies for a long time. But in recent years, there has been a growing number of people discontented with these platforms. A lot of conservative-leaning individuals have been feeling censored by the big tech. Source: Dmitry Demidovich/ShutterStock.com This has created an opportunity for companies like Rumble, slated to
0 Comments
Novavax (NASDAQ:NVAX) still remains poised to sell its vaccine for the coronavirus to many countries around the world, likely enabling it to generate very strong revenue in 2022 and possibly into 2023. Yet NVAX stock has fallen sharply in recent days. Source: rarrarorro / Shutterstock.com That makes the shares very attractive for medium-term investors. Shares
0 Comments
With Meta Platforms (NASDAQ:FB) stock facing dangerous threats and unlikely to generate big returns for investors over the next year or two, I don’t believe that the shares are a buy for any type of medium-term or long-term investor. Meta Platforms is the company formerly known as Facebook. Source: Chinnapong / Shutterstock.com Among the biggest risks
0 Comments
Electric vehicle startup Lucid Group (NASDAQ:LCID) has seen some wild swings in recent months. Between mid-October and mid-November, LCID stock more than doubled in price before quickly reversing and falling more than 30% into its early December low. Source: ggTravelDiary / Shutterstock.com The sell-off included an 18% single-day drop on news the U.S. Securities and
0 Comments